RSS

oral solid dosage form (OSDF)

Glenmark Pharmaceuticals to set up a new manufacturing facility in the US

The facility will be spread over 100,000 sq. ft (around 15 acre plot) and the company will first begin work on an oral solid unit and thereafter set up manufacturing units for injectables and topicals. more »

Jul 17, 2014 12:31 PM

Growth foreseen at all levels of OSDF market globally

The oral solid dosage form (OSDF) excipients market is growing sustainably on a global scale, historically exhibiting a robust increase. This market is valued at nearly $2.3 billion (£1.4/€1.7 billion) in the US, Europe, India, and China... more »

Apr 29, 2014 10:47 AM Technology

Lonza Extends Partnership with Pharmacyclics to Support Manufacturing of Approved Oncology Therapeutic

Supplier in chemical development and manufacturing Lonza has established an agreement with Pharmacyclics, Inc. to support the commercial and clinical production of its oral oncology drug IMBRUVICA (Ibrutinib). This agreement follows a successful... more »

Jan 13, 2014 3:23 PM Technology

Aesica Unveils £30 Mn High Capacity Manufacturing Facility for Type 2 Diabetes Medication

Aesica has announced the creation of a new High Capacity Manufacturing Facility following a £30 million investment at its Queenborough, Kent site. The 10,000 m2 expansion has been constructed for the production of a solid dose medication used in... more »

Sep 19, 2013 11:35 AM Technology

Product Line Extension with User-Friendly Solid Dosage Forms

HERMES PHARMA is an expert in developing and manufacturing user-friendly solid oral dosage forms such as effervescent and chewable tablets, lozenges, instant drinks and orally disintegrating granules. These dosage forms are rapidly gaining... more »

Aug 22, 2013 10:32 AM News

CDMO Enters Collaboration to Promote Abuse Deterrence Technology

Aesica Pharmaceuticals has announced the signing of an agreement between its subsidiary, Aesica Formulation Development Ltd, and QRxPharma Ltd for the global promotion of QRxPharma’s proprietary Stealth Beadlets abuse deterrence technology. more »

Jul 22, 2013 3:18 PM Technology

FDA Inspection Opens Door for Increased Production of User-Friendly Solid Dosage Forms

Hermes Pharma, a division of Hermes Arzneimittel GmbH, recently completed a successful inspection by the FDA of its production facility in Wolfratshausen, Germany. The inspection stemmed from Hermes Pharma’s status as a manufacturer of food... more »

Jun 26, 2013 12:26 PM Technology

Capacity Investment Meets Growing Demand for Sugar Spheres

To meet the increase in demand for Suglets sugar spheres, Colorcon is investing to increase capacity and reduce lead-time, thereby reducing customers’ supply risk while ensuring premium quality and consistent product. more »

Jun 6, 2013 4:58 PM Technology

User-Friendly Oral Dosage Forms Made Possible with Hermes

Hermes Pharma is an expert in developing and manufacturing user-friendly solid oral dosage forms, including effervescent and chewable tablets, lozenges, instant drinks and orally disintegrating granules. more »

Mar 7, 2013 10:05 AM Home

Solubilisation Expert to Expand Pharma Center of Excellence in Delaware

Ashland has announced plans to expand its pharmaceutical research and development Center of Excellence at the Ashland Research Center in Wilmington, US. Ashland will be expanding its existing capabilities to include formulation development and GMP... more »

Mar 5, 2013 4:30 PM Technology

Oral Drug Delivery Specialist Names Global Development and Licensing Efforts Leader

Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma that develops differentiated products utilising its oral delivery technologies, has announced that Nigel Ray has been named as the company’s Vice President of Global Licensing. more »

Feb 14, 2013 2:56 PM Technology

Partnership to Advance Knowledge in Solid Oral Dosage Engineering Operations and Instrumentation

Natoli Engineering and the Arnold and Marie Schwartz College of Pharmacy and Health Sciences at Long Island University have announced a partnership to establish The Natoli Engineering Institute for Industrial Pharmacy Development and Research. more »

Jan 31, 2013 2:18 PM Technology

Die Table Segment Technology Enables Up to 25% Increase in Production

Tablet production rate is one of the most important criteria when assessing economic viability of a tablet press. For this reason, increasing the performance, particularly on presses that are already in operation, has enormous significance. more »

Jan 17, 2013 3:09 PM Technology

Built with Metro Publisher™